193 related articles for article (PubMed ID: 38344714)
1. LIF/JAK2/STAT1 Signaling Enhances Production of Galactose-Deficient IgA1 by IgA1-Producing Cell Lines Derived From Tonsils of Patients With IgA Nephropathy.
Yamada K; Huang ZQ; Reily C; Green TJ; Suzuki H; Novak J; Suzuki Y
Kidney Int Rep; 2024 Feb; 9(2):423-435. PubMed ID: 38344714
[TBL] [Abstract][Full Text] [Related]
2. Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy.
Yamada K; Huang ZQ; Raska M; Reily C; Anderson JC; Suzuki H; Kiryluk K; Gharavi AG; Julian BA; Willey CD; Novak J
Kidney Dis (Basel); 2020 May; 6(3):168-180. PubMed ID: 32523959
[TBL] [Abstract][Full Text] [Related]
3. Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
Reily C; Rice T; Crossman DK; Rizk DV
J Autoimmun; 2022 Oct; 132():102883. PubMed ID: 35987175
[TBL] [Abstract][Full Text] [Related]
4. GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy.
Jemelkova J; Stuchlova Horynova M; Kosztyu P; Zachova K; Zadrazil J; Galuszkova D; Takahashi K; Novak J; Raska M
Kidney Int Rep; 2023 May; 8(5):1068-1075. PubMed ID: 37180502
[TBL] [Abstract][Full Text] [Related]
5. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
Makita Y; Suzuki H; Kano T; Takahata A; Julian BA; Novak J; Suzuki Y
Kidney Int; 2020 Feb; 97(2):340-349. PubMed ID: 31748116
[TBL] [Abstract][Full Text] [Related]
6. Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.
Kawabe M; Yamamoto I; Yamakawa T; Katsumata H; Isaka N; Katsuma A; Nakada Y; Kobayashi A; Koike K; Ueda H; Tanno Y; Koike Y; Miki J; Yamada H; Kimura T; Ohkido I; Tsuboi N; Yamamoto H; Kojima H; Yokoo T
Front Immunol; 2020; 11():2068. PubMed ID: 33013875
[No Abstract] [Full Text] [Related]
7. Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.
Suzuki H; Moldoveanu Z; Julian BA; Wyatt RJ; Novak J
Kidney Int Rep; 2019 Dec; 4(12):1717-1724. PubMed ID: 31844808
[TBL] [Abstract][Full Text] [Related]
8. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
9. Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy.
Wang M; Lv J; Zhang X; Chen P; Zhao M; Zhang H
Kidney Int Rep; 2020 Feb; 5(2):165-172. PubMed ID: 32043030
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Ohta K; Yachie A
J Immunol Res; 2020; 2020():4284379. PubMed ID: 32537466
[TBL] [Abstract][Full Text] [Related]
11. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
Reily C; Ueda H; Huang ZQ; Mestecky J; Julian BA; Willey CD; Novak J
J Immunol Res; 2014; 2014():197548. PubMed ID: 25152896
[TBL] [Abstract][Full Text] [Related]
12. ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome.
Liu Y; Wang F; Zhang Y; Jia J; Yan T
J Cell Mol Med; 2020 Sep; 24(18):10493-10500. PubMed ID: 32677771
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity.
Liang Y; Zeng Q; Wang XH; Yan L; Yu RH
Biomed Res Int; 2023; 2023():5124034. PubMed ID: 36660452
[TBL] [Abstract][Full Text] [Related]
14. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
Elíasdóttir S; Khramova A; Saeed A; Guron G; Boi R; Mölne J; Ebefors K; Nyström J
BMC Nephrol; 2023 Jun; 24(1):160. PubMed ID: 37286948
[TBL] [Abstract][Full Text] [Related]
16. IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1via the TLR4 signaling pathway.
Zhu Y; He H; Sun W; Wu J; Xiao Y; Peng Y; Hu P; Jin M; Liu P; Zhang D; Wu J; Xie T; Huang L; He W; Wei M; Wang L; Xu X; Tang Y
Nephrol Dial Transplant; 2024 Feb; ():. PubMed ID: 38402460
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
Liu Y; Liu X; Jia J; Zheng J; Yan T
J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
[TBL] [Abstract][Full Text] [Related]
18. Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
Sun Q; Zhang Z; Zhang H; Liu X
PLoS One; 2016; 11(11):e0166700. PubMed ID: 27870872
[TBL] [Abstract][Full Text] [Related]
19. ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy.
Liu Y; Zheng J; Zhao N; Jia J; Yan T
Dis Markers; 2019; 2019():2407067. PubMed ID: 31275443
[TBL] [Abstract][Full Text] [Related]
20. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
